» Articles » PMID: 35766751

Prevalence of the Human Immunodeficiency Virus and Associated Factors in Pregnant Women in the State of Pará

Abstract

Objectives: to analyze the prevalence of the Human Immunodeficiency Virus and the associated factors in pregnant women in the state of Pará.

Methods: retrospective, analytical, quantitative study with a sample of 332 medical records of HIV-positive pregnant women hospitalized at the Referral Maternity Hospital in the state of Pará between 2010 and 2019. Bivariate and multivariate statistical analysis were performed with the variables collected.

Results: the average prevalence in the period was 2.39% and the Metropolitan Region concentrated 66.87% of cases. There was a strong relationship between the number of antenatal consultations and lack of knowledge of serological status (p value equal to 0.01E-17) variables, and a correlation between the education and number of antenatal consultations variables.

Conclusions: the increase in the infection rate during the study period revealed the need to intensify health actions, early diagnosis and strategies to improve adherence to antiretroviral treatment for maternal viral suppression and reduction of the risk of vertical transmission, contributing to improve public policies.

References
1.
Li H, Liu J, Tan D, Huang G, Zheng J, Xiao J . Maternal HIV infection and risk of adverse pregnancy outcomes in Hunan province, China: A prospective cohort study. Medicine (Baltimore). 2020; 99(8):e19213. PMC: 7034691. DOI: 10.1097/MD.0000000000019213. View

2.
Muyunda B, Musonda P, Mee P, Todd J, Michelo C . Educational Attainment as a Predictor of HIV Testing Uptake Among Women of Child-Bearing Age: Analysis of 2014 Demographic and Health Survey in Zambia. Front Public Health. 2018; 6:192. PMC: 6102411. DOI: 10.3389/fpubh.2018.00192. View

3.
Patel D, Taylor-Aidoo N, Marandet A, Heitgerd J, Maciak B . Assessing Differences in CDC-Funded HIV Testing by Urbanicity, United States, 2016. J Community Health. 2018; 44(1):95-102. PMC: 6349234. DOI: 10.1007/s10900-018-0558-1. View

4.
Cerveny L, Murthi P, Staud F . HIV in pregnancy: Mother-to-child transmission, pharmacotherapy, and toxicity. Biochim Biophys Acta Mol Basis Dis. 2021; 1867(10):166206. DOI: 10.1016/j.bbadis.2021.166206. View

5.
Feitoza H, Koifman R, Saraceni V . [Evaluation of missed opportunities in the control of vertical HIV transmission in Rio Branco, Acre State, Brazil]. Cad Saude Publica. 2021; 37(3):e00069820. DOI: 10.1590/0102-311X00069820. View